Hunan Jingfeng Pharmaceutical

The Hunan Securities Regulatory Bureau announced on August 18 that Ye Xianglun, a concert party of Ye Xiangwu, a shareholder holding more than 5% of CSPC Jingfeng, was ordered to buy back the shares sold in violation and surrender the price difference to the listed company, because he sold 250,000 shares of CSPC Jingfeng through centralized bidding on July 3, 2026, without reporting and disclosing the reduction plan as required beforehand.

Shiyao Jingfeng announced that 2.5 million shares held by Ye Xiangwu, a shareholder with more than 5 percent stake, will undergo a second judicial auction from September 3 to September 6, 2026. These shares account for 2.88 percent of Ye Xiangwu's holdings and 0.14 percent of the company's total share capital. As of the announcement date, the cumulative number of Ye Xiangwu's shares subject to auction is 2.5 million, representing 2.88 percent of his holdings and 0.14 percent of the company's total share capital. In the first quarter of 2026, Shiyao Jingfeng recorded revenue of 108 million yuan and net profit attributable to the parent company of 3.67 million yuan.

Ye Xiangwu, a shareholder holding more than 5% of Shiyao Jingfeng, has pledged 32.17 million shares, representing 29.45% of his holdings and 1.83% of the company's total share capital. As of the announcement date, Ye Xiangwu has cumulatively pledged 41.58 million shares, accounting for 38.06% of his holdings and 2.36% of the company's total share capital. In the first quarter of 2026, the company achieved revenue of 108 million yuan and a net profit attributable to the parent company of 3.67 million yuan.